Answers are grounded in this paper and cite their sources.
Hematologists have a significant role in the diagnosis and management of light-chain amyloidosis and are frequently involved in the diagnosis of transthyretin and other more rare types of amyloidosis. Recent advances in diagnostic techniques and therapies are dramatically improving patient prognosis. Radionuclide imaging methods are emerging as a highly specific and noninvasive way to diagnose, quantify, and monitor organ involvement representing a major advance in amyloidosis management.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: